Michaux, Jean-Louis
[UCL]
Martiat, P.
Chronic myelomonocytic leukaemia (CMML), a disorder belonging to the group of myelodysplastic syndromes, has a number of peculiar features which raise the question as to whether it should be considered a distinct entity in its own right. The problems associated with its classification and diagnosis are discussed in this report using all currently available tools from clinical data to molecular genetics, including morphology, histology, cellular biology and cytogenetics. Three groups of patients can be identified (isolated monocytosis with a mild degree of dysplasia, severe cytopenia and the most frequent type with proliferative symptoms dominating the clinical picture). The latter group is close to atypical chronic myeloid leukaemia and perhaps these two entities should be regarded as a single one. Classification of the disease is further complicated by the possibility of evolution from one subgroup into another one and by the finding that CMML can also arise as a disorder secondary to other myeloproliferative (MPS) or myelodysplastic (MDS) syndromes. No specific marker of the disease has been identified by cytogenetics or molecular biology. Due to all these facts, we believe that CMML should perhaps be viewed more pragmatically by considering the use of prognostic factors that could at least help to define different groups of patients who may require different therapeutic strategies. We conclude that CMML is a heterogeneous syndrome with features of both MPS and MDS, encompassing primary and secondary stem cell disorders and varying widely in its clinical presentation. This heterogeneity should stimulate the search for reliable predictors of evolution which would allow a better definition of CMML subtypes based on prognostic factors.
- Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., Proposals for the classification of the myelodysplastic syndromes, 10.1111/j.1365-2141.1982.tb08475.x
- Dameshek W, Blood, 6, 372 (1951)
- Martiat P., Blood, 78, 205 (1991)
- GROUPEFRANCAISDECYTOGENETIQUE, Cytogenetics of chronic myelomonocytic leukemia, 10.1016/0165-4608(86)90197-4
- GROUPEFRANCAISDECYTOGENETIQUE, Chronic myelomonocytic leukemia: Single entity or heterogeneous disorder?A prospective multicenter study of 100 patients, 10.1016/0165-4608(91)90235-m
- Kantarjian H. M., Hematolo-gy/Oncology Clinics of North America, 4, 389 (1990)
- Storniolo A. M., Leukemia, 4, 766 (1990)
- Cogswell P. C., Blood, 74, 2629 (1989)
- Van Den Berghe Herman, Broeckaert-van Orshoven Angeline, Louwagie Andries, Verwilghen Robrecht, Michaux Jean-Louis, Sokal Gerard, Transformation of polycythemia vera to myelofibrosis and late appearance of a 5q— Chromosome anomaly, 10.1016/0165-4608(79)90021-9
- Worsley A., Oscier D. G., Stevens J., Darlow S., Figes Ann, Mufti G. J., Hamblin T. J., Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival, 10.1111/j.1365-2141.1988.tb04173.x
- Stark AN, Thorogood J, Head C, Roberts BE, Scott CS, Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML), 10.1038/bjc.1987.154
- Solal-Celigny P., Blood, 63, 634 (1984)
- Fenaux P., Journal of Clinical Oncology, 6, 1417 (1988)
- Ribera Josep-Maria, Cervantes Francisco, Reverter Juan-Carlos, Montserrat Emilio, Rozman Ciril, Acute transformation of chronic myelomonocytic leukaemia: a multivariate study of predictive factors, 10.1111/j.1600-0609.1989.tb00113.x
- Alessandrino E. P., Orlandi E., Brusamolino E., Lazzarino M., Morra E., Castagnola C., Bernasconi C., Chronic myelomonocytic leukemia: Clinical features, cytogenetics, and prognosis in 30 consecutive cases, 10.1002/hon.2900030206
- Goldman J M, Th'ng K H, Lowenthal R M, In vitro Colony Forming Cells and Colony Stimulating Factor in Chronic Granulocytic Leukaemia, 10.1038/bjc.1974.108
- Heyll A., Derigs G., Chronic Myelomonocytic Leukemia: Clinical Data, Morphological Features, and Outcome in 56 Patients, Acute Leukemias II (1990) ISBN:9783540509844 p.387-391, 10.1007/978-3-642-74643-7_73
- Goasguen J. E., Seminars in Oncology, 19, 4 (1992)
- Albrecht Marianne, „Gaucher-Zellen” bei chronisch myeloischer Leukämie, 10.1007/bf01635454
- Pike Beverley L., Robinson William A., Human bone marrow colony growth in agar-gel, 10.1002/jcp.1040760111
- Sultan C., Annales de Médecine Interne, 125, 599 (1974)
- Mertelsmann R., Moore M. A. S., Clarkson B. D., Sequential Marrow Culture Studies and Terminal Deoxynucleotidyl Transferase Activities in Myelodysplastic Syndromes, Preleukemia (1979) ISBN:9783540096986 p.106-117, 10.1007/978-3-642-67470-9_20
- Hamblin T. J., Oscier D. G., The myelodysplastic syndrome—a practical guide, 10.1002/hon.2900050104
- Sandberg A. A, The chromosomes in human cancer and leukemia (1990)
- Yuo Akira, Miyazono Kohei, Urabe Akio, Takaku Fumimaro, Characteristics of Granulocyte-Macrophage Colony Formation in Chronic Myelomonocytic Leukemia: A Comparative Study with Other Myelodysplastic and Myeloproliferative Disorders, 10.1111/j.1349-7006.1990.tb02651.x
- Verma Dharmvir S., Spitzer Gary, Dicke Karel A., McCredie Kenneth B., In vitro agar culture patterns in preleukemia and their clinical significance, 10.1016/0145-2126(79)90007-9
- Kerkhofs H., Hermans J., Haak H. L., Leeksma C. H. W., Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases, 10.1111/j.1365-2141.1987.tb06138.x
- Pugh William C., Pearson Marilyn, Vardiman James W., Rowley Janet D., Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment, 10.1111/j.1365-2141.1985.tb07443.x
- Becher R., Blood, 75, 1679 (1990)
- Nowell P. C, Seminars in Oncology, 19, 25 (1992)
- Berkowicz M., Rosner E., Rechavi G., Mamon Z., Neuman Y., Ben-Bassat I., Ramot B., Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12), 10.1016/0165-4608(91)90142-h
- Hirsch-Ginsberg C., Blood, 76, 1214 (1990)
- Padua R. A., Leukemia, 2, 503 (1988)
- Ahuja H. G., Blood, 75, 1684 (1990)
- List A. F., Seminars in Oncology, 19, 14 (1992)
- Goasguen Jean-Etienne, Garand Richard, Bizet Marie, Bremond Jean-Louis, Gardais Jacques, Callat Marie Pierre, Accard Françoise, Chaperon Jacques, Prognostic factors of myelodysplastic syndromes—A simplified 3-D scoring system, 10.1016/0145-2126(90)90133-t
- Shepherd Patricia C.A., Ganesan T.S., Galton David A.G., Haematological classification of the chronic myeloid leukaemias, 10.1016/s0950-3536(87)80031-8
- Kantarjian Hagop M., Shtalrid Mordechai, Kurzrock Razelle, Buck Marc, Dalton Willard T., Lemaistre Ann, Stass Sanford A., McCredie Kenneth B., Gutterman Jordan, Freireich Emil J., Talpaz Moshe, Significance and correlations of molecular analysis results in patients with philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia, 10.1016/s0002-9343(88)80235-3
- Alimena G., Dallapiccola B., Gastaldi R., Mandelli F., Brandt L., Mitelman F., Nilsson P. G., Chromosomal, Morphological and Clinical Correlations in Blastic Crisis of Chronic Myeloid Leukaemia A Study of 69 Cases, 10.1111/j.1600-0609.1982.tb00502.x
- Mufti G. J., Stevens J. R., Oscier D. G., Hamblin T. J., Machin D., Myelodysplastic syndromes: a scoring system with prognostic significance, 10.1111/j.1365-2141.1985.tb07329.x
- del Canizo M. C., Cancer Genetics Cytogenetics, 42, 466 (1989)
Bibliographic reference |
Michaux, Jean-Louis ; Martiat, P.. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?. In: Leukemia & lymphoma, Vol. 9, no. 1-2, p. 35-41 (1993) |
Permanent URL |
http://hdl.handle.net/2078.1/12123 |